The experie
nce and insights of Oxford PharmaGenesis into founding its office in Basel are highlighted in a feature in the September issue of Director magazine (the publication of the UK Institute of Directors).
The feature focuses on UK company expansion into Switzerland and includes quotes from an interview with Dr Richard White, Commercial Director of Oxford PharmaGenesis and a member of the Institute of Directors.
“Nearly half of our global revenue comes from companies with headquarters in Switzerland, and so understanding how to do business there has been an important part of our success,” says Richard. “Our vision is to have a Swiss-based operation that provides local delivery expertise as well as local client liaison, and we are currently engaging with UK Trade & Investment, Swiss trade organizations and our clients to understand which of our services are most relevant to companies in Basel and beyond.”
Oxford PharmaGenesis is growing its office in Switzerland and is looking for adaptable, service-driven people with strong scientific credentials and a desire to make a difference to a fast-growing global company. For further information, please contact Richard (Richard White) or Chris Winchester (Managing Director; Chris Winchester).
